FIELD: biotechnology.
SUBSTANCE: present invention relates to novel modified nucleic acids. Present invention describes, in particular, a compound of general formula (I) (where each symbol has the value given in the description), or salts thereof, as well as an oligonucleotide compound having general formula (I') (where each symbol has the value given in the description), or a salt thereof.
EFFECT: invention discloses a novel bridged artificial nucleic acid and an oligomer containing it as a monomer.
33 cl, 150 ex, 11 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 2-OXA-5-AZABICYCLO[2.2.1]HEPTANE-3-YL DERIVATIVES | 2015 |
|
RU2697651C2 |
| CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
| FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
| PYRIDO[3,4-D]PYRIMIDINE DERIVATIVE AND ITS PHARMACEUTICALLY ACCEPTABLE SALT | 2017 |
|
RU2796400C2 |
| SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE DERIVATIVES OF PYRIMIDINES, COMPOSITIONS THEREOF AND METHODS OF TREATING USE THEREOF | 2012 |
|
RU2697712C2 |
| SUBSTITUTED DIAMINO-CARBOXAMIDE AND DIAMINO-CARBONITRILE PYRIMIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF TREATMENT USING THEM | 2012 |
|
RU2625309C2 |
| DIFLUOROMETHYLAMINOPYRIDINES AND DIFLUOROMETHYLAMINOPYRIMIDINES | 2015 |
|
RU2712091C2 |
| LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
| ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH | 2020 |
|
RU2786588C1 |
| BORONIC ACID DERIVATIVES | 2018 |
|
RU2793315C2 |
